11β-hydroxylase deficiency epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency in United States is approximately 1 per 100,000 individuals. | * The prevalence of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency in United States is approximately 1 per 100,000 individuals. | ||
===Incidence=== | ===Incidence=== | ||
* Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency accounts for 5 to 8 percent of all cases of congenital adrenal hyperplasia. It is estimated that CAH due to 11-beta-hydroxylase deficiency occurs in 1 in 100,000 to 200,000 newborns. This condition is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns | |||
===Case Fatality Rate=== | ===Case Fatality Rate=== | ||
* The casefatality rate of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is highest. | |||
===Age=== | ===Age=== | ||
* Patients of all age groups may develop congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood. | |||
===Gender=== | ===Gender=== | ||
* Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency affects male and female equally. | * Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency affects male and female equally. | ||
===Race=== | ===Race=== | ||
* Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency usually affects individuals of the Jewish race. | * Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency usually affects individuals of the Jewish race. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:37, 26 January 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency epidemiology and demographics |
|
FDA on 11β-hydroxylase deficiency epidemiology and demographics |
|
CDC on 11β-hydroxylase deficiency epidemiology and demographics |
|
11β-hydroxylase deficiency epidemiology and demographics in the news |
|
Blogs on 11β-hydroxylase deficiency epidemiology and demographics |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Epidemiology and Demographics
Prevalence
- The prevalence of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency in United States is approximately 1 per 100,000 individuals.
Incidence
- Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency accounts for 5 to 8 percent of all cases of congenital adrenal hyperplasia. It is estimated that CAH due to 11-beta-hydroxylase deficiency occurs in 1 in 100,000 to 200,000 newborns. This condition is more common in Moroccan Jews living in Israel, occurring in approximately 1 in 5,000 to 7,000 newborns
Case Fatality Rate
- The casefatality rate of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency is highest.
Age
- Patients of all age groups may develop congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. The mean age of diagnosis is infancy and childhood.
Gender
- Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency affects male and female equally.
Race
- Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency usually affects individuals of the Jewish race.